Neuraxis, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.0% | +2.9% | +2.2% | -15.5% | -26.1% | -7.2% | +102.7% | +25.8% | +48.4% | -32.2% | +2.0% | – | |
| – | -170.6% | – | +182.0% | -65.2% | -72.7% | +42.9% | +63.5% | -7.4% | -2.0% | +109.6% | +94.2% | – | |
| – | – | -45.7% | -8.1% | -168.3% | – | – | -98.1% | +4,652.1% | -189.8% | – | +228.9% | – | |
| – | +499.9% | -8.2% | -41.0% | -49.7% | -99.9% | +599,900.0% | -59.5% | -100.0% | +586,100.0% | -99.9% | +210,000.0% | – | |
| – | – | – | -41.0% | -49.7% | – | – | -59.5% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -151.7% | +21.9% | -17.5% | -19.4% | +1.7% | +0.8% | – | |
| – | -45.0% | -31.2% | +145.0% | -103.2% | – | -101.3% | – | -103.4% | – | +27.2% | -31.8% | – | |
| – | -196.2% | – | +52,641.9% | -189.4% | – | -149.2% | – | -140.5% | – | +259.5% | -41.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.